Thermo Fisher Sells $750M in Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it had sold a total of $750 million worth of senior notes through two offerings.

The firm said that it issued $450 million worth of 3.2 percent senior notes due 2015 and $300 million of 4.7 percent senior notes due 2020. The notes mature on May 1 of their respective years. Interest is payable twice a year on Nov. 1 and May 1, beginning with Nov. 1 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.